Pesticide packaging waste in Thailand has recently been valued as a kind of commercial product. Selling empty pesticide packaging to reuse/recycling business has been increased in all over the country. Subject to the ...Pesticide packaging waste in Thailand has recently been valued as a kind of commercial product. Selling empty pesticide packaging to reuse/recycling business has been increased in all over the country. Subject to the resource conservation and global climate change, this could be defined as sustainable or green consumption for the most beneficial use of natural resources. However, on the point of environmental and public health, this is the way to disperse harmfulness of pesticide into non-target areas. Human and environmental health risk of exposure due to pesticide residue in such packaging waste could be a co-incident. This paper was aimed to determine a practical model for pesticide packaging waste management appropriate for Thailand based on the context of country＇s circumstances and the best practices reported around the world. Establishing some necessary components has been proposed, i.e. multiple rinse method applied by farmers conscientiously, central collecting site driven by local community, waste recovery program offered by pesticide production enterprises, and sanitary glass bottle washing plant registration and regulations launched by the government. In conclusion, governmental initiative and all stakeholders including in pesticide packaging waste supply chain should be encouraged to contribute their participation towards sustainable management.展开更多
Aim： EPO （erythropoietin） is a hormone that stimulates the erythropoiesis and is mainly produced by the kidneys. In the early 1990s among the emerging biotech drugs, the recombinant human EPO （rhEPO） was the best...Aim： EPO （erythropoietin） is a hormone that stimulates the erythropoiesis and is mainly produced by the kidneys. In the early 1990s among the emerging biotech drugs, the recombinant human EPO （rhEPO） was the best-selling product worldwide, reaching nearly three billion dollars annually. The CIM （center of molecular immunology） produced and sold the rhEPO as commercial strategy to recover the investment made in its new facilities. This work summarizes the inventions that protect the innovative products developed by three Cuban institutions, starting from rhEPO, and the industrial property strategy followed by them. Methods： The information was obtained from the United States Patent, Trademark Office （USPTO） database, Patentscope, Espacenet, patent databases of Center for Pharmaceutical Research and Drug Development （CIDEM） and Cuban Industrial Property Office. Conclusions： The manufacturing process of CIM＇s EPO has its own patent family. From a manufacturing by product an innovative formulation protected by patent was obtained. There is a patent family around the nasal formulation and it continues enlarging. From a biosimilar pharmaceutical innovative products impacting on human health have been obtained.展开更多
文摘Pesticide packaging waste in Thailand has recently been valued as a kind of commercial product. Selling empty pesticide packaging to reuse/recycling business has been increased in all over the country. Subject to the resource conservation and global climate change, this could be defined as sustainable or green consumption for the most beneficial use of natural resources. However, on the point of environmental and public health, this is the way to disperse harmfulness of pesticide into non-target areas. Human and environmental health risk of exposure due to pesticide residue in such packaging waste could be a co-incident. This paper was aimed to determine a practical model for pesticide packaging waste management appropriate for Thailand based on the context of country＇s circumstances and the best practices reported around the world. Establishing some necessary components has been proposed, i.e. multiple rinse method applied by farmers conscientiously, central collecting site driven by local community, waste recovery program offered by pesticide production enterprises, and sanitary glass bottle washing plant registration and regulations launched by the government. In conclusion, governmental initiative and all stakeholders including in pesticide packaging waste supply chain should be encouraged to contribute their participation towards sustainable management.
文摘Aim： EPO （erythropoietin） is a hormone that stimulates the erythropoiesis and is mainly produced by the kidneys. In the early 1990s among the emerging biotech drugs, the recombinant human EPO （rhEPO） was the best-selling product worldwide, reaching nearly three billion dollars annually. The CIM （center of molecular immunology） produced and sold the rhEPO as commercial strategy to recover the investment made in its new facilities. This work summarizes the inventions that protect the innovative products developed by three Cuban institutions, starting from rhEPO, and the industrial property strategy followed by them. Methods： The information was obtained from the United States Patent, Trademark Office （USPTO） database, Patentscope, Espacenet, patent databases of Center for Pharmaceutical Research and Drug Development （CIDEM） and Cuban Industrial Property Office. Conclusions： The manufacturing process of CIM＇s EPO has its own patent family. From a manufacturing by product an innovative formulation protected by patent was obtained. There is a patent family around the nasal formulation and it continues enlarging. From a biosimilar pharmaceutical innovative products impacting on human health have been obtained.
